Bone Marrow Iron in CKD: Correlation With Functional Iron Deficiency

American Journal of Kidney Diseases

Volumn 55, Issue 4, 2010, Pages 617-621

  Hung, Szu Chun ^a   Tarng, Der Cherng ^b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; FERRIC HYDROXIDE SUCROSE; FERROPORTIN; HEPCIDIN;

ACCURACY; ANEMIA; BONE MARROW BIOPSY; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DISEASE SEVERITY; EDITORIAL; ERYTHROPOIESIS; FERRITIN BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; IRON BONE MARROW LEVEL; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON STORAGE; IRON THERAPY; IRON TRANSPORT; OXIDATIVE STRESS; TISSUE LEVEL; TRANSFERRIN SATURATION; TREATMENT OUTCOME;

BONE MARROW; CHRONIC DISEASE; HUMANS; IRON; KIDNEY DISEASES;

EID: 77949552106     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.12.027     Document Type: Editorial

References (36)

1. Obrador G.T., Roberts T., St. Peter W.L., et al. Trends in anemia at initiation of dialysis in the United States. Kidney Int 60 (2001) 1875-1884
2. Wen C.P., Cheng T.Y.D., Tsai M.K., et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462293 adults in Taiwan. Lancet 371 (2008) 2173-2182
3. Tarng D.C. Cardiorenal anemia syndrome in chronic kidney disease. J Chin Med Assoc 70 (2007) 424-429
4. Tarng D.C., Huang T.P., Chen T.W., et al. Erythropoietin hyporesponsiveness: from iron deficiency to iron overload. Kidney Int Suppl 69 (1999) S107-S118
5. Cavill I. Intravenous iron as adjuvant therapy: a two-edged sword?. Nephrol Dial Transplant 18 (2003) viii24-viii28
6. Kuo K.L., Hung S.C., Wei Y.H., and Tarng D.C. Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients. J Am Soc Nephrol 19 (2008) 1817-1826
7. Drueke T., Witko-Sarsat V., Massy Z., et al. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 106 (2002) 2212-2217
8. Stancu S., Stanciu A., Zugravu A., et al. Bone marrow iron, iron indices, and the response to intravenous iron in patients with non-dialysis-dependent CKD. Am J Kidney Dis 55 4 (2010) 639-647
9. Fishbane S. Iron management in nondialysis-dependent CKD. Am J Kidney Dis 49 (2007) 736-743
10. Besarab A., and Levin A. Defining a renal anemia management period. Am J Kidney Dis 36 suppl 6 (2000) S13-S23
11. Fishbane S., Pollack S., Feldman H.I., and Joffe M.M. Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004. Clin J Am Soc Nephrol 4 (2009) 57-61
12. National Kidney Foundation. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. Am J Kidney Dis 47 suppl 3 (2006) S1-S146
13. Witko-Sarsat V., Friedlander M., Capeillere-Blandin C., et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49 (1996) 1304-1313
14. Stenvinkel P., Heimburger O., Paultre F., et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55 (1999) 1899-1911
15. Tarng D.C., Huang T.P., Wei Y.H., et al. 8-Hydroxy-2′-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis 36 (2000) 934-944
16. Young B., and Zaritsky A. Hepcidin for clinicians. Clin J Am Soc Nephrol 4 (2009) 1384-1387
17. Gotloib L., Silverberg D., and Shostak A. Iron deficiency is a very common cause of anemia in chronic kidney insufficiency and can often be corrected with IV iron. J Nephrol 19 (2006) 161-167
18. Rahman M.M., Dutta P.K., Hoque M., et al. Evaluation of iron status by bone marrow iron stain and correlation with serum profile in chronic kidney disease (CKD). J Bangladesh Coll Physicians Surg 25 (2007) 117-120
19. Fernandez-Rodriguez A.M., Guindeo-Casasus M.C., Molero-Labarta T., et al. Diagnosis of iron deficiency in chronic renal failure. Am J Kidney Dis 34 (1999) 508-513
20. Domrongkitchaiporn S., Jirakranont B., Atamasrikul K., et al. Indices of iron status in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 34 (1999) 29-35
21. Kalantar-Zedeh K., Hoffken B., Wunsch H., Fink H., Kleiner M., and Luft F.C. Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis 26 (1995) 292-299
22. Tham K.T., Cousar J.B., and Macon W.R. Silver stain for ringed sideroblasts. A sensitive method that differs from Perls' reaction in mechanism and clinical application. Am J Clin Pathol 94 (1990) 73-76
23. Bain B., Clark D., and Lampert I. The normal bone marrow. Bone Marrow Pathology. 2nd ed. (1992), Blackwell Science, Oxford, UK 3-30
24. Nissenson A.R., and Strobos J. Iron deficiency in patients with renal failure. Kidney Int Suppl 69 (1999) S18-S21
25. Fong T.P., Okafor L.A., Thomas Jr. W., and Westerman M.P. Stainable iron in aspirated and needle-biopsy specimens of marrow: a source of error. Am J Hematol 2 (1977) 47-51
26. Van Wyck D.B., Roppolo M., Martinez C.O., et al. A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. Kidney Int 68 (2005) 2846-2856
27. Barron B.A., Hoyer J.D., and Tefferi A. A bone marrow report of absent stainable iron is not diagnostic of iron deficiency. Ann Hematol 80 (2001) 166-169
28. Fishbane S., Kowalski E.A., Imbriano L.J., and Maesaka J.K. The evaluation of iron status in hemodialysis patients. J Am Soc Nephrol 7 (1996) 2654-2657
29. Tessitore N., Solero G.P., Lippi G., et al. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrol Dial Transplant 16 (2001) 1416-1423
30. Mittman N., Sreedhara R., Mushnick R., et al. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO. Am J Kidney Dis 30 (1997) 912-922
31. Chuang C.L., Liu R.S., Wei Y.H., Huang T.P., and Tarng D.C. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. Nephrol Dial Transplant 18 (2003) 370-377
32. Chen Y.C., Hung S.C., and Tarng D.C. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients. Am J Kidney Dis 47 (2006) 1036-1044
33. Tarng D.C. The conundrum of serum ferritin measurement in patients with chronic kidney disease. Nat Clin Practice Nephrol 5 (2009) 66-67
34. Ford B.A., Coyne D.W., Eby C.S., and Scott M.G. Variability of ferritin measurements in chronic kidney disease; implications for iron management. Kidney Int 75 (2009) 104-110
35. Wish J.B. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 1 suppl 1 (2006) S4-S8
36. Brugnara C. A hematologic "gold standard" for iron-deficient states?. Clin Chem 48 (2002) 981-982